Leukostasis retinopathy treated with Anti-VEGF therapy
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2020.100677
Abstract: A 48-year-old male otherwise asymptomatic presented to the eye clinic with sudden onset bilateral vision loss. Pertinent history revealed well-controlled Type II Diabetes Mellitus. Visual acuity was Counting Fingers on the right and 20/400 on… read more here.
Keywords: leukostasis retinopathy; left eye; retinopathy treated; treated anti ... See more keywords
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.03.006
Abstract: BACKGROUND Programmed death receptor-1 blocking antibodies (anti-PD1) are a new standard of care in many cancer types. Patients benefit from improved survival but have the risk of immune-related adverse events (irAE). We evaluated if medical… read more here.
Keywords: detection; patients treated; immune related; treated anti ... See more keywords
Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti‐PD‐1
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14678
Abstract: Pembrolizumab(®) , a first line immune checkpoint inhibitor, has shown good clinical activity with an acceptable safety profile, in the management of metastatic melanoma.(1, 2) We report a patient with metastatic melanoma, treated with anti-PD-1,… read more here.
Keywords: melanoma; regression; treated anti; metastatic melanoma ... See more keywords
THU0366 Gastrointestinal infections in patients with spondyloarthritis treated with anti-tnf drugs: results of gisea register
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.5936
Abstract: Background Tumour necrosis factor (TNF) plays a pivotal role in controlling intracellular of bacterial infection. The BSR Biologics Register (BSRBR) has reported an increase in the occurrence of listeria and salmonella infections in anti-TNF-treated rheumatoid… read more here.
Keywords: tnf drugs; treated anti; anti tnf; gastrointestinal infections ... See more keywords
Risk factors for pneumonitis in solid tumors treated with anti-programmed death-1 therapy: A case-control study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15132
Abstract: e15132Background: Despite its great efficacy in patients with solid tumors, immune checkpoint blockade (ICB) might also lead to a series of inflammatory effects known as immune-related adverse even... read more here.
Keywords: solid tumors; factors pneumonitis; risk factors; treated anti ... See more keywords
Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody
Sign Up to like & getrecommendations! Published in 2018 at "In Vivo"
DOI: 10.21873/invivo.11462
Abstract: Background/Aim: Red cell distribution width (RDW) has been reported to reflect the inflammation and nutrition status and predict prognosis of non-small cell lung cancer (NSCLC) patients treated with anti-programmed cell death-1 (PD-1) antibody. The aim… read more here.
Keywords: cell distribution; prognosis; antibody; treated anti ... See more keywords
Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.756872
Abstract: Aim Immune checkpoint inhibitors (ICIs) have updated the treatment landscape for patients with advanced malignancies, while their clinical prospect was hindered by severe immune-related adverse events (irAEs). The aim of this study was to research… read more here.
Keywords: study; adverse events; immune related; treated anti ... See more keywords
Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.981001
Abstract: Immunocheckpoint inhibitors have shown significant efficacy in the treatment of hepatocellular carcinoma (HCC), but there are individual differences. The aim of this study was to explore body mass index (BMI) as a predictor of anti-PD-1… read more here.
Keywords: hepatocellular carcinoma; overweight patients; patients treated; body mass ... See more keywords
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1108119
Abstract: Background There are few studies on medical conditions associated with the development of drug-resistant TB. Objective We investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB. Materials… read more here.
Keywords: tuberculosis patients; mdr; patients treated; risk ... See more keywords
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.635237
Abstract: Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with poor prognosis and limited treatment options. Recent studies have reported overexpression of programmed death ligand 1 (PD-L1) in metaplastic breast cancers,… read more here.
Keywords: metastatic metaplastic; breast; metaplastic breast; case series ... See more keywords
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081186
Abstract: Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNFα (non-anti-TNFα) or to… read more here.
Keywords: anti tnf; tnf; patients inflammatory; inflammatory bowel ... See more keywords